Research Topics
| Gagan JoshiSummaryAffiliation: Harvard University Country: USA Publications
|
Detail Information
Publications
The heavy burden of psychiatric comorbidity in youth with autism spectrum disorders: a large comparative study of a psychiatrically referred populationGagan Joshi
Pediatric Psychopharmacology Research Department, Massachusetts General Hospital, Boston, MA, USA
J Autism Dev Disord 40:1361-70. 2010..These findings emphasize the heavy burden of psychiatric comorbidity afflicting youth with ASD and may be important targets for intervention...- Comorbidity in pediatric bipolar disorderGagan Joshi
Pervasive Developmental Disorders Program, Clinical and Research Programs in Pediatric Psychopharmacology, Massachusetts General Hospital, Harvard Medical School, 32 Fruit Street, Boston, MA 02114, USA
Child Adolesc Psychiatr Clin N Am 18:291-319, vii-viii. 2009..Future longitudinal studies to address the relationship and the impact of comorbid disorders on course and therapeutic response over time are required in youth with BPD... 
Discriminant and concurrent validity of a simplified DSM-based structured diagnostic instrument for the assessment of autism spectrum disorders in youth and young adultsGagan Joshi
Clinical and Research Program in Pediatric Psychopharmacology, Massachusetts General Hospital, Boston, MA, USA
BMC Psychiatry 11:204. 2011..To evaluate the concurrent and discriminant validity of a brief DSM-based structured diagnostic interview for referred individuals with autism spectrum disorders (ASDs)...- A prospective open-label trial of quetiapine monotherapy in preschool and school age children with bipolar spectrum disorderGagan Joshi
Clinical and Research Program in Pediatric Psychopharmacology, Massachusetts General Hospital, Boston, MA 02114, USA
J Affect Disord 136:1143-53. 2012..This study evaluates the response to quetiapine monotherapy in preschool and school age children with bipolar spectrum disorder (BSD)... - Response to second generation antipsychotics in youth with comorbid bipolar disorder and autism spectrum disorderGagan Joshi
Pediatric Psychopharmacology Research Department, Massachusetts General Hospital, USA
CNS Neurosci Ther 18:28-33. 2012..To assess the impact of comorbid autism spectrum disorders (ASD) on the response to second-generation antipsychotics (SGA) in pediatric bipolar disorder (BPD)... - Impact of obsessive-compulsive disorder on the antimanic response to olanzapine therapy in youth with bipolar disorderGagan Joshi
Pediatric Psychopharmacology Research Program, Massachusetts General Hospital, Boston, MA 02114, USA
Bipolar Disord 12:196-204. 2010..To compare antimanic response to olanzapine therapy in youth with bipolar disorder (BPD) based on the status of comorbidity with obsessive-compulsive disorder (OCD)... - Clinical characteristics of comorbid obsessive-compulsive disorder and bipolar disorder in children and adolescentsGagan Joshi
Pediatric Psychopharmacology Research Program, Massachusetts General Hospital, Boston, MA 02114, USA
Bipolar Disord 12:185-95. 2010.... - Child behavior checklist clinical scales discriminate referred youth with autism spectrum disorder: a preliminary studyJoseph Biederman
Clinical and Research Program in Pediatric Psychopharmacology, Massachusetts General Hospital, Boston, MA 02114, USA
J Dev Behav Pediatr 31:485-90. 2010.... - A prospective open-label trial of extended-release carbamazepine monotherapy in children with bipolar disorderGagan Joshi
Pediatric Psychopharmacology Research Department, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
J Child Adolesc Psychopharmacol 20:7-14. 2010..The aim of this study was to evaluate the safety and efficacy of extended release carbamazepine (CBZ-ER) monotherapy in the treatment of pediatric bipolar disorder (BD)... - A prospective open-label trial of lamotrigine monotherapy in children and adolescents with bipolar disorderJoseph Biederman
Clinical and Research Program in Pediatric Psychopharmacology, Massachusetts General Hospital, Boston, MA, USA
CNS Neurosci Ther 16:91-102. 2010..To evaluate the safety and efficacy of lamotrigine monotherapy as an acute treatment of bipolar mood elevation in children with bipolar spectrum disorders... - Do stimulants reduce the risk for cigarette smoking in youth with attention-deficit hyperactivity disorder? A prospective, long-term, open-label study of extended-release methylphenidatePaul Hammerness
Clinical and Research Program in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02138, USA
J Pediatr 162:22-7.e2. 2013..Although attention-deficit hyperactivity disorder (ADHD) is a well-known risk factor for cigarette smoking, prospective studies aimed at reducing smoking risk in this population are critically needed... - Atomoxetine in children with attention-deficit hyperactivity disorder with prior stimulant therapy: a prospective open-label studyPaul Hammerness
Clinical and Research Program in Pediatric Psychopharmacology and Adult ADHD, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
Eur Child Adolesc Psychiatry 18:493-8. 2009..In conclusion, atomoxetine was generally well tolerated; 85% of subjects completed the trial. Atomoxetine was effective and well tolerated in a 6-week open study of ADHD youth with a prior history of stimulant treatment... - Does ADHD predict substance-use disorders? A 10-year follow-up study of young adults with ADHDTimothy E Wilens
Clinical and Research Program in Pediatric Psychopharmacology, Massachusetts General Hospital, Boston MA 02114, USA
J Am Acad Child Adolesc Psychiatry 50:543-53. 2011..The main aims of this study were to identify clinically meaningful characteristics of children that predicted the future development of SUDs and to see whether the role of these characteristics varied by sex... 
An open-label trial of aripiprazole monotherapy in children and adolescents with bipolar disorderJoseph Biederman
Joint Program in Pediatric Psychopharmacology Research Office, Massachusetts General Hospital, Boston, MA 02114, USA
CNS Spectr 12:683-9. 2007..Aripiprazole is a novel second-generation antipsychotic approved for the treatment of bipolar disorder in adults but there is no systematic data available in pediatric bipolar disorder...- Risperidone treatment for ADHD in children and adolescents with bipolar disorderJoseph Biederman
Pediatric Psychopharmacology Research Department, Massachusetts General Hospital Boston, MA, USA
Neuropsychiatr Dis Treat 4:203-7. 2008..The objective of this study was to estimate improvement in ADHD symptoms in children with bipolar disorder... - Treatment of pediatric obsessive-compulsive disorder: a reviewElizabeth Mancuso
Clinical and Research Program in Pediatric Psychopharmacology, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02138, USA
J Child Adolesc Psychopharmacol 20:299-308. 2010..The purpose of this article is to review assessment and treatment strategies to include current advances in research...